Welcome to Jiangxi Yuneng Pharmaceutical Co., Ltd.
    Your Position:Home > News Center  > Entreprise's news
    1. The drug substance industry eliminates hidden dangers

      [2019-03-11]

      Continuously extending and shifting to the downstream supply chain, domestic deep processing capabilities are gradually increasing.

    2. The transformation of APIs depends on many factors. Innovation is the key.

      [2019-03-11]

      With the continuous upgrading of the development of the pharmaceutical industry at home and abroad, the export profits of bulk pharmaceutical raw materials in China have been greatly reduced, which has triggered a crisis in the development of the industry.

    3. Improving the domestic pharmaceutical innovation market system is the prerequisite for the transform

      [2019-03-11]

      Technological innovation in the API industry is a very complex system engineering innovation system involving pharmacy, chemistry, biology, informatics, engineering, mechanical technology and so on.

    4. China's hormonal API exports stepped into the normal trade track

      [2019-03-11]

      According to China Customs statistics, in 2014, the export value of hormonal APIs in China increased by 52.99% year-on-year, achieving the largest increase since the European debt crisis.

    5. Innovation in the API industry requires both corporate and government

      [2019-03-11]

      Technological innovation in the API industry is a very complex system engineering innovation system involving pharmacy, chemistry, biology, informatics, engineering, mechanical technology and so on.